Comment
Abstract title
FOLFIRINOX vs. gemcitabine + nab-paclitaxel in the first line treatment setting of metastatic pancreatic cancer- a single institution analysis of the outcomes
First author
MATEA BULJUBAŠIĆ FRANIĆ
Your name
Your E-mail address
Your message
